Innovatiefonds Noord-Holland (INH) has invested in three promising startups in Amsterdam: Phosphoenix BV, Amplio Pharma, and Parkinnova Therapeutics. Phosphoenix focuses on developing a neurotech prosthesis to partially restore vision for blind individuals using a camera-based system. Amplio Pharma works on enhancing existing drugs, while Parkinnova is targeting new therapies for Parkinson's disease. INH, a collaboration of various academic and health institutions, provides support during the Proof-of-Concept phase through convertible loans, helping innovators and academics launch their projects successfully.
Phosphoenix has a unique neurotech solution to (partially) restore the vision of blind people. With this financing from Innovatiefonds Noord-Holland, we hope to advance this groundbreaking technology.
The fund supports entrepreneurs in Noord-Holland during the Proof-of-Concept phase through convertible loans, managing two funds for innovative and academic starters.
Phosphoenix BV is developing a prosthesis with a camera that translates visual information into electrical signals, enabling blind individuals to perceive simplified images.
Founded in 2019 from research at the Netherlands Institute for Neuroscience, Phosphoenix aims to restore vision through innovative medical technology.
Collection
[
|
...
]